Madrigal Pharmaceuticals, Inc. share price logo

Madrigal Pharmaceuticals, Inc. Share Price

NASDAQ: MDGL

Mid Cap

$435.05

-4.95

(-1.12%)

as on

Madrigal Pharmaceuticals, Inc. Stock Performance

as on February 26, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $435.00
    $447.00
    downward going graph

    0.01%

    Downside

    2.75%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $265.00
    $615.00
    downward going graph

    39.09%

    Downside

    41.36%

    Upside

    downward going graph

Madrigal Pharmaceuticals, Inc. share price movements today

Previous Close
$440.00
Open
$440.00
Volume
326.4K
Day's Low - High
$435.00 - $447.00
52 Week Low - High
$265.00 - $615.00

Madrigal Pharmaceuticals, Inc. Historical Returns

1 Month Return
-12.85 %
3 Month Return
-27.62 %
1 Year Return
+ 22.24 %
3 Year Return
+ 57.5 %
5 Year Return
+ 258.95 %

Madrigal Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Madrigal Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.0B

EPS (TTM)

-5.7275

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-298.6M

Revenue (TTM)

958.4M

Profit Margin

-30.08%

Return On Equity TTM

-42.49%

Madrigal Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Madrigal Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$10.0B258.95%NA-30.08%
BUY$44.1B121.04%142.858.45%
NA$40.8BNA709.621.38%
BUY$123.8B127.26%31.8432.94%
BUY$81.6B74.06%18.6231.41%

Stock Returns calculator for Madrigal Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Madrigal Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Madrigal Pharmaceuticals, Inc. investment value today

Current value as on today

₹1,26,573

Returns

₹26,573

(+26.57%)

Returns from Madrigal Pharmaceuticals, Inc. Stock

₹22,246 (+22.25%)

Dollar Returns*

₹4,326 (+4.33%)

Analyst Recommendation on Madrigal Pharmaceuticals, Inc. Stock

Based on 21 analysts

BUY

80.95%

Buy

14.29%

Hold

4.76%

Sell

Based on 21 analysts, 80.95% of analysts recommend a 'BUY' rating for Madrigal Pharmaceuticals, Inc.. Average target price of $667.57

Madrigal Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Madrigal Pharmaceuticals, Inc..

What analysts predicted

34.83%UPSIDE

Target Price

$667.57

Current Price

$435.05

Analyzed by

21 Analysts

Target

$667.57

Madrigal Pharmaceuticals, Inc. target price $667.57, a slight upside of 34.83% compared to current price of $435.05. According to 21 analysts rating.

Madrigal Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest

Search interest for Madrigal Pharmaceuticals, Inc. Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Madrigal Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
14
62
103
137
212
287
321
Gross Profit
0
0
0
14
60
99
132
203
269
296
Operating Income
-98
-117
-152
-162
-116
-66
-79
-47
-113
-59
EBITDA
-95
-108
-143
-148
-102
-55
-69
-38
-106
-85
Interest Expense
3
3
3
3
3
3
3
3
7
8
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-98
-112
-147
-151
-106
-59
-73
-42
-114
-58
Income Tax Expense
0
0
0
-
0
-
-
-
-
-
Net Income
-98
-112
-147
-151
-106
-59
-73
-42
-114
-58
Net Profit Margin
0.00%
-14570.65%
0.00%
-1038.20%
-172.04%
-57.51%
-53.36%
-19.87%
-39.75%
-18.24%

Madrigal Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
-
0
0
-
-
180
958
Gross Profit
0
0
0
0
0
0
0
0
173
902
Operating Income
-25
-32
-40
-94
-206
-242
-293
-380
-497
-300
EBITDA
-25
-31
-40
-94
-206
-242
-290
-360
-450
-298
Interest Expense
1
0
7
11
4
1
3
12
14
22
Depreciation
-
0
0
0
0
0
0
0
1
-
Income Before Tax
-26
-31
-32
-83
-202
-241
-295
-373
-465
-288
Income Tax Expense
0
0
7
-11
-4
0
3
-
-465
-
Net Income
-26
-31
-32
-72
-197
-241
-295
-373
-465
-288
Net Profit Margin
0.00%
-8901.14%
-16405.50%
0.00%
-903055.25%
-646009.97%
0.00%
0.00%
-258.64%
-30.08%

Madrigal Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-112
-147
-151
-106
-59
-73
-42
-114
-58
Operating Cash Flow
-79
-149
-134
-66
-104
-88
-47
79
-133
Investing Cash Flow
-362
98
-122
-202
-47
163
47
-206
27
Financing Cash Flow
479
573
134
7
19
8
1
236
8
Change in Cash
37
522
-122
-261
-132
83
2
109
-96

Madrigal Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-32
-83
-202
-241
-295
-373
-465
-288
Operating Cash Flow
-22
-25
-41
-157
-183
-224
-324
-455
-189
Investing Cash Flow
-22
-380
30
159
-5
206
-502
-274
32
Financing Cash Flow
173
314
0
5
171
313
595
735
255
Change in Cash
129
-91
-10
7
-17
295
-231
5
98

Global Institutional Holdings in Madrigal Pharmaceuticals, Inc.

Funds
Holdings
Pictet Asset Manangement SA
0.93%
Citadel Advisors Llc
0.93%
HHG PLC
9.83%
T. Rowe Price Associates, Inc.
2.28%
UBS Group AG
2.27%

Insights on Madrigal Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 42.5% return, outperforming this stock by 18.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 71.2% return, outperforming this stock by 11.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, MDGL stock has moved down by -26.8%

About Madrigal Pharmaceuticals, Inc.

madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.
OrganisationMadrigal Pharmaceuticals, Inc.
HeadquartersFour Tower Bridge, West Conshohocken, PA, United States, 19428
IndustryHealth Technology
CEOMr. William J. Sibold
E-voting on sharesClick here to vote

Key Management of Madrigal Pharmaceuticals, Inc.

Name

Title

Ms. Tina E. Ventura

Chief Investor Relations Officer

Mr. Clint Wallace

Executive VP & Chief Human Resources Officer

Mr. William J. Sibold

CEO, President & Director

Dr. Rebecca A. Taub M.D.

Founder, Senior Scientific & Medical Advisor and Director

Ms. Carole Huntsman

Executive VP & Chief Commercial Officer

Mr. Ronald Filippo

Executive VP & Chief Information Officer

Ms. Mardi C. Dier

Executive VP & CFO

Ms. Shannon Kelley

Executive VP, Chief Legal Officer & Corporate Secretary

Mr. Mark Underwood

Executive Vice President of Business Planning & Operations

Ms. Rita Thakkar

Senior VP & Chief Accounting Officer

FAQs

What is Madrigal Pharmaceuticals, Inc. share price today?

Madrigal Pharmaceuticals, Inc. share price today is $435.05 as on at the close of the market. Madrigal Pharmaceuticals, Inc. share today touched a day high of $447 and a low of $435.

What is the 52 week high and 52 week low for Madrigal Pharmaceuticals, Inc. share?

Madrigal Pharmaceuticals, Inc. share touched a 52 week high of $615 on and a 52 week low of $265 on . Madrigal Pharmaceuticals, Inc. stock price today i.e. is closed at $435.05,which is 29.26% down from its 52 week high and 64.17% up from its 52 week low.

What is Madrigal Pharmaceuticals, Inc.'s market capitalisation today?

Madrigal Pharmaceuticals, Inc. market capitalisation is $0.01T as on .

How to invest in Madrigal Pharmaceuticals, Inc. Stock (MDGL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Madrigal Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Madrigal Pharmaceuticals, Inc. Shares that will get you 0.0034 shares as per Madrigal Pharmaceuticals, Inc. share price of $435.05 per share as on February 26, 2026 at 2:29 am IST.

What is the minimum amount required to buy Madrigal Pharmaceuticals, Inc. Stock (MDGL) from India?

Indian investors can start investing in Madrigal Pharmaceuticals, Inc. (MDGL) shares with as little as ₹90.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹909.10 in Madrigal Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Madrigal Pharmaceuticals, Inc. share’s latest price of $435.05 as on February 26, 2026 at 2:29 am IST, you will get 0.0230 shares of Madrigal Pharmaceuticals, Inc.. Learn more about fractional shares .

What are the returns that Madrigal Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Madrigal Pharmaceuticals, Inc. stock has given 258.95% share price returns and 25.12% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?